PL3087989T3 - Preparaty stałe zawierające tofogliflozynę i sposób ich wytwarzania - Google Patents

Preparaty stałe zawierające tofogliflozynę i sposób ich wytwarzania

Info

Publication number
PL3087989T3
PL3087989T3 PL14874030T PL14874030T PL3087989T3 PL 3087989 T3 PL3087989 T3 PL 3087989T3 PL 14874030 T PL14874030 T PL 14874030T PL 14874030 T PL14874030 T PL 14874030T PL 3087989 T3 PL3087989 T3 PL 3087989T3
Authority
PL
Poland
Prior art keywords
tofogliflozin
producing
same
solid preparations
preparations
Prior art date
Application number
PL14874030T
Other languages
English (en)
Inventor
Kenta Wada
Tomoaki Hirayama
Kenichi Sakai
Shiho YOSHIMURA
Original Assignee
Chugai Seiyaku Kabushiki Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Seiyaku Kabushiki Kaisha filed Critical Chugai Seiyaku Kabushiki Kaisha
Publication of PL3087989T3 publication Critical patent/PL3087989T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL14874030T 2013-12-27 2014-12-26 Preparaty stałe zawierające tofogliflozynę i sposób ich wytwarzania PL3087989T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2013273060 2013-12-27
PCT/JP2014/084561 WO2015099139A1 (ja) 2013-12-27 2014-12-26 トホグリフロジンを含有する固形製剤及びその製造方法
EP14874030.1A EP3087989B1 (en) 2013-12-27 2014-12-26 Solid preparations comprising tofogliflozin and method for producing the same

Publications (1)

Publication Number Publication Date
PL3087989T3 true PL3087989T3 (pl) 2019-07-31

Family

ID=53478978

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14874030T PL3087989T3 (pl) 2013-12-27 2014-12-26 Preparaty stałe zawierające tofogliflozynę i sposób ich wytwarzania

Country Status (22)

Country Link
US (2) US10231930B2 (pl)
EP (2) EP3482748A1 (pl)
JP (5) JP6513030B2 (pl)
KR (2) KR20210082557A (pl)
CN (2) CN105828826B (pl)
AU (1) AU2014370847B2 (pl)
BR (1) BR112016013164B1 (pl)
CA (1) CA2934832C (pl)
DK (1) DK3087989T3 (pl)
ES (1) ES2704065T3 (pl)
HK (1) HK1224221A1 (pl)
HR (1) HRP20182199T1 (pl)
HU (1) HUE041983T2 (pl)
LT (1) LT3087989T (pl)
MX (2) MX370342B (pl)
PL (1) PL3087989T3 (pl)
PT (1) PT3087989T (pl)
RU (1) RU2700164C2 (pl)
SI (1) SI3087989T1 (pl)
TR (1) TR201821042T4 (pl)
TW (2) TWI715523B (pl)
WO (1) WO2015099139A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2674428T1 (sl) 2006-04-07 2016-07-29 Vertex Pharmaceuticals Incorporated Modulatorji transporterjev atp-vezavne kasete
AU2014370847B2 (en) * 2013-12-27 2020-02-20 Chugai Seiyaku Kabushiki Kaisha Solid preparations containing tofogliflozin and process of producing the same
CN108640958B (zh) * 2017-05-05 2021-03-30 镇江圣安医药有限公司 异苯并呋喃衍生物、其药物组合物和制剂以及用途
CN107811983A (zh) * 2017-12-04 2018-03-20 威海贯标信息科技有限公司 一种托格列净组合物
CN107759649A (zh) * 2017-12-12 2018-03-06 威海贯标信息科技有限公司 一种托格列净新晶型

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56145214A (en) 1980-04-11 1981-11-11 Taiho Yakuhin Kogyo Kk Ubidecarenone tablet
JP2626975B2 (ja) 1987-03-30 1997-07-02 エーザイ株式会社 低融点油性物質含有錠剤
ES2082723B1 (es) 1994-07-20 1996-10-01 Lilly Sa Formulacion farmaceutica de fluoxetina en forma dispersable.
JPH10287561A (ja) 1997-04-11 1998-10-27 Taisho Pharmaceut Co Ltd イブプロフェン配合固形製剤及びその製造方法
JP2000239185A (ja) 1999-02-16 2000-09-05 Taisho Pharmaceut Co Ltd 医薬組成物
CA2524827A1 (en) 2003-05-06 2004-11-25 Nirmal Mulye Controlled release formulation of erythromycin derivatives
JP2005104934A (ja) 2003-10-01 2005-04-21 Eisai Co Ltd 新規組成物及びその製造方法
JP4997741B2 (ja) 2004-11-12 2012-08-08 大正製薬株式会社 低融点薬物含有粉粒体及びその製造方法
TW200637869A (en) * 2005-01-28 2006-11-01 Chugai Pharmaceutical Co Ltd The spiroketal derivatives and the use as therapeutical agent for diabetes of the same
PE20090185A1 (es) * 2007-03-22 2009-02-28 Bristol Myers Squibb Co Formulaciones farmaceuticas que contienen un inhibidor sglt2
JP4072195B2 (ja) 2007-10-18 2008-04-09 キッセイ薬品工業株式会社 速放性経口医薬組成物
TW201011043A (en) * 2008-06-20 2010-03-16 Chugai Pharmaceutical Co Ltd Crystal of spiroketal derivatives and process for preparation of spiroketal derivatives
NZ594024A (en) * 2009-02-13 2013-08-30 Boehringer Ingelheim Int Pharmaceutical composition comprising glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process for their preparation and uses thereof for improved glycemic control in a patient
US20130035281A1 (en) * 2011-02-09 2013-02-07 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
WO2012115249A1 (ja) 2011-02-25 2012-08-30 中外製薬株式会社 スピロケタール誘導体の結晶
AU2012264736A1 (en) 2011-06-03 2013-11-28 Boehringer Ingelheim International Gmbh SGLT-2 inhibitors for treating metabolic disorders in patients treated with neuroleptic agents
PT2981269T (pt) 2013-04-04 2023-10-10 Boehringer Ingelheim Vetmedica Gmbh Tratamento de distúrbios metabólicos em animais equinos
AU2014370847B2 (en) * 2013-12-27 2020-02-20 Chugai Seiyaku Kabushiki Kaisha Solid preparations containing tofogliflozin and process of producing the same

Also Published As

Publication number Publication date
HK1224221A1 (zh) 2017-08-18
RU2016130602A (ru) 2018-02-01
SI3087989T1 (sl) 2019-03-29
RU2016130602A3 (pl) 2018-06-08
US10398653B2 (en) 2019-09-03
MX2019008865A (es) 2019-09-13
LT3087989T (lt) 2019-02-11
KR20160101719A (ko) 2016-08-25
JP2020203918A (ja) 2020-12-24
CN105828826B (zh) 2021-04-06
JP6759390B2 (ja) 2020-09-23
TR201821042T4 (tr) 2019-01-21
JP6513030B2 (ja) 2019-05-15
CA2934832C (en) 2022-03-15
EP3482748A1 (en) 2019-05-15
TWI715523B (zh) 2021-01-11
US20160324786A1 (en) 2016-11-10
PT3087989T (pt) 2019-02-26
MX370342B (es) 2019-12-10
US10231930B2 (en) 2019-03-19
BR112016013164B1 (pt) 2022-07-26
US20190151248A1 (en) 2019-05-23
DK3087989T3 (en) 2019-03-25
JP2024063140A (ja) 2024-05-10
TW202126311A (zh) 2021-07-16
TWI774159B (zh) 2022-08-11
EP3087989A1 (en) 2016-11-02
CN105828826A (zh) 2016-08-03
HUE041983T2 (hu) 2019-06-28
RU2700164C2 (ru) 2019-09-13
JP2019112424A (ja) 2019-07-11
EP3087989A4 (en) 2017-09-20
CN113058038B (zh) 2024-01-12
JPWO2015099139A1 (ja) 2017-03-23
WO2015099139A1 (ja) 2015-07-02
BR112016013164A2 (pl) 2017-08-08
AU2014370847B2 (en) 2020-02-20
ES2704065T3 (es) 2019-03-14
TW201609194A (zh) 2016-03-16
JP2022116267A (ja) 2022-08-09
HRP20182199T1 (hr) 2019-02-22
CN113058038A (zh) 2021-07-02
KR102395687B1 (ko) 2022-05-06
MX2016008527A (es) 2016-09-13
CA2934832A1 (en) 2015-07-02
KR20210082557A (ko) 2021-07-05
AU2014370847A1 (en) 2016-06-16
EP3087989B1 (en) 2018-12-19

Similar Documents

Publication Publication Date Title
HK1206755A1 (en) Low acidic species compositions and methods for producing and using the same
SG10201407632UA (en) Transducer and method for forming the same
ZA201507161B (en) Dental devices and systems and methods for making the same
PT3065845T (pt) Sistema de filtragem e método para operar um sistema de filtragem
EP3006415B8 (en) Method for producing nanocement and nanocement
EP3008170A4 (en) SC-CELLS AND COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF
ZA201604328B (en) 1,2-naphthoquinone derivative and method for preparing same
EP2949783A4 (en) LUBICLE ELEMENT AND METHOD FOR THE PRODUCTION THEREOF
IL240665A0 (en) Improved aluminum-magnesium-lithium alloys and methods for their production
HRP20182199T1 (hr) Kruti pripravci koji sadrže tofogliflozin i postupak za njihovu proizvodnju
GB201406038D0 (en) Autotroph-based deodorizer and method for manufacturing the same
EP3089951A4 (en) Ceramic and method for preparing the same
EP3057435A4 (en) Structured triacylglycerols and methods for making the same
IL240423B (en) Arrangement for a filter and method for its use
ZA201509017B (en) Pcd elements and process for making the same
EP3021772A4 (en) Spinal construct and method
ZA201602129B (en) Audiometry system and method
SG11201701354VA (en) Oligosaccharide preparation and method for producing the same
PL3091005T3 (pl) Pochodna 1,2-naftochinonu i sposób jej wytwarzania
EP2756766B8 (en) Brine and method for the manufacture thereof
HK1204129A1 (en) Cashier system and method for operating the cashier system
IL246199A0 (en) Tampon and method for its preparation
EP3052484A4 (en) Sulfonylindole derivatives and method for preparing the same
EP3001881A4 (en) PHOTOVOLTAIC DEVICES AND METHODS OF MAKING THE SAME
PT2980096T (pt) Métodos de preparação de 2,3,5 tri-hidroxi-androst-6-ona e utilização do mesmo